Icecure Medical Net Income
| ICCM Stock | USD 0.57 0.02 3.39% |
As of the 13th of February 2026, Icecure Medical retains the Standard Deviation of 3.21, market risk adjusted performance of (0.15), and Risk Adjusted Performance of (0.05). Icecure Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Icecure Medical mean deviation, information ratio, as well as the relationship between the Information Ratio and potential upside to decide if Icecure Medical is priced fairly, providing market reflects its last-minute price of 0.57 per share. As Icecure Medical is a penny stock we also advise to confirm its jensen alpha numbers.
Icecure Medical Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 10.5774 | Revenue | Earnings Share (0.25) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -13.8 M | -13.1 M | |
| Net Loss | -13.8 M | -14.5 M | |
| Net Loss | -15.3 M | -16 M | |
| Net Loss | (0.27) | (0.28) | |
| Net Income Per E B T | 0.91 | 0.81 |
Icecure | Net Income | Build AI portfolio with Icecure Stock |
Evaluating Icecure Medical's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Icecure Medical's fundamental strength.
Latest Icecure Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Icecure Medical over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Icecure Medical financial statement analysis. It represents the amount of money remaining after all of Icecure Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Icecure Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Icecure Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (15.32 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Icecure Net Income Regression Statistics
| Arithmetic Mean | (7,653,983) | |
| Coefficient Of Variation | (66.11) | |
| Mean Deviation | 4,495,552 | |
| Median | (4,714,004) | |
| Standard Deviation | 5,060,147 | |
| Sample Variance | 25.6T | |
| Range | 14.3M | |
| R-Value | (0.79) | |
| Mean Square Error | 10.4T | |
| R-Squared | 0.62 | |
| Significance | 0.0002 | |
| Slope | (787,647) | |
| Total Sum of Squares | 409.7T |
Icecure Net Income History
Other Fundumenentals of Icecure Medical
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Icecure Medical Net Income component correlations
Icecure Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Icecure Medical is extremely important. It helps to project a fair market value of Icecure Stock properly, considering its historical fundamentals such as Net Income. Since Icecure Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Icecure Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Icecure Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could Icecure diversify its offerings? Factors like these will boost the valuation of Icecure Medical. Market participants price Icecure higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Icecure Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.25) | Revenue Per Share | Quarterly Revenue Growth 0.284 | Return On Assets | Return On Equity |
Understanding Icecure Medical requires distinguishing between market price and book value, where the latter reflects Icecure's accounting equity. The concept of intrinsic value - what Icecure Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Icecure Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Icecure Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Icecure Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Icecure Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Icecure Medical.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Icecure Medical on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Icecure Medical or generate 0.0% return on investment in Icecure Medical over 90 days. Icecure Medical is related to or competes with Spectral, Cytosorbents Crp, Tela Bio, Sensus Healthcare, Telomir Pharmaceuticals, Baird Medical, and Electrocore LLC. IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical de... More
Icecure Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Icecure Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Icecure Medical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 14.72 | |||
| Value At Risk | (5.88) | |||
| Potential Upside | 4.35 |
Icecure Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Icecure Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Icecure Medical's standard deviation. In reality, there are many statistical measures that can use Icecure Medical historical prices to predict the future Icecure Medical's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | (0.16) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Icecure Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Icecure Medical February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.15) | |||
| Mean Deviation | 2.47 | |||
| Coefficient Of Variation | (1,348) | |||
| Standard Deviation | 3.21 | |||
| Variance | 10.32 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | (0.16) | |||
| Maximum Drawdown | 14.72 | |||
| Value At Risk | (5.88) | |||
| Potential Upside | 4.35 | |||
| Skewness | 0.2024 | |||
| Kurtosis | 0.3206 |
Icecure Medical Backtested Returns
Icecure Medical holds Efficiency (Sharpe) Ratio of -0.0964, which attests that the entity had a -0.0964 % return per unit of risk over the last 3 months. Icecure Medical exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Icecure Medical's Market Risk Adjusted Performance of (0.15), risk adjusted performance of (0.05), and Standard Deviation of 3.21 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.6, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Icecure Medical will likely underperform. At this point, Icecure Medical has a negative expected return of -0.31%. Please make sure to check out Icecure Medical's jensen alpha and the relationship between the potential upside and price action indicator , to decide if Icecure Medical performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.50 |
Modest predictability
Icecure Medical has modest predictability. Overlapping area represents the amount of predictability between Icecure Medical time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Icecure Medical price movement. The serial correlation of 0.5 indicates that about 50.0% of current Icecure Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.5 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Icecure Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Icecure Medical reported net income of (15.32 Million). This is 104.49% lower than that of the Health Care Equipment & Supplies sector and 106.43% lower than that of the Health Care industry. The net income for all United States stocks is 102.68% higher than that of the company.
Icecure Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Icecure Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Icecure Medical could also be used in its relative valuation, which is a method of valuing Icecure Medical by comparing valuation metrics of similar companies.Icecure Medical is currently under evaluation in net income category among its peers.
Icecure Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Icecure Medical from analyzing Icecure Medical's financial statements. These drivers represent accounts that assess Icecure Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Icecure Medical's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 87.1M | 57.4M | 48.8M | 56.0M | 50.4M | 60.5M | |
| Enterprise Value | 62.4M | 34.3M | 38.9M | 48.9M | 44.0M | 59.2M |
Icecure Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Icecure Medical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Icecure Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Icecure Medical's value.| Shares | Efficient Wealth Management Llc | 2025-06-30 | 5 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1.8 K | Bank Of America Corp | 2025-06-30 | 862 | Royal Bank Of Canada | 2025-06-30 | 500 | Bartlett & Co Wealth Management Llc | 2025-06-30 | 250 | Sbi Securities Co Ltd | 2025-06-30 | 3.0 | Tower Research Capital Llc | 2025-03-31 | 0.0 | Renaissance Technologies Corp | 2025-03-31 | 0.0 | Xtx Topco Ltd | 2025-06-30 | 0.0 | Citadel Advisors Llc | 2025-06-30 | 52.5 K | Geode Capital Management, Llc | 2025-06-30 | 40.5 K |
Icecure Fundamentals
| Return On Equity | -1.58 | ||||
| Return On Asset | -0.63 | ||||
| Operating Margin | (4.51) % | ||||
| Current Valuation | 31.47 M | ||||
| Shares Outstanding | 68.96 M | ||||
| Shares Owned By Insiders | 40.40 % | ||||
| Shares Owned By Institutions | 0.66 % | ||||
| Number Of Shares Shorted | 548.03 K | ||||
| Price To Book | 4.43 X | ||||
| Price To Sales | 13.70 X | ||||
| Revenue | 3.29 M | ||||
| Gross Profit | 1.04 M | ||||
| EBITDA | (15.36 M) | ||||
| Net Income | (15.32 M) | ||||
| Cash And Equivalents | 17.73 M | ||||
| Cash Per Share | 0.48 X | ||||
| Total Debt | 459 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 4.99 X | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | (12.56 M) | ||||
| Short Ratio | 1.83 X | ||||
| Earnings Per Share | (0.25) X | ||||
| Target Price | 3.13 | ||||
| Number Of Employees | 64 | ||||
| Beta | 2.21 | ||||
| Market Capitalization | 40.76 M | ||||
| Total Asset | 12.58 M | ||||
| Retained Earnings | (105.38 M) | ||||
| Working Capital | 5.24 M | ||||
| Net Asset | 12.58 M |
About Icecure Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Icecure Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icecure Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icecure Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Will Health Care Equipment & Supplies sector continue expanding? Could Icecure diversify its offerings? Factors like these will boost the valuation of Icecure Medical. Market participants price Icecure higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Icecure Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.25) | Revenue Per Share | Quarterly Revenue Growth 0.284 | Return On Assets | Return On Equity |
Understanding Icecure Medical requires distinguishing between market price and book value, where the latter reflects Icecure's accounting equity. The concept of intrinsic value - what Icecure Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Icecure Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Icecure Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.